Insiders · Profile

Trout Harry R. III

See Remarks at ENANTA PHARMACEUTICALS. Filing since 2 Dec 2025. CIK 0002085123

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2025
See Remarks
Sold at will
542
$7.71K
3.2%
2 Dec 2025
See Remarks
Sold at will
380
$5.30K
2.2%
2 decisions on file.